The product is used to detect Influenza / RSV / Covid-19 antigen by qualitative analysis. detection of human saliva, nasopharyngeal and oropharyngeal swabs. The laboratory diagnostic method is virus isolation and culture, and cell culture
The identification cycle is approximately 14 hours, which seriously affects the timely medication orientation for patients in clinical practice, which has limited clinical application. Compared to cell culture, reverse transcription-polymerase chain reaction (RT-PCR)
It has higher sensitivity, but the cost of RT-PCR is higher, the experimental time needs 4-6 hours, and is highly professional in laboratory operation, so your submitted application is limited. The latex chromatogram product used is suitable for the diagnosis of influenza A, influenza B, RSV and Covid-19.
For in vitro diagnostic use only. For professional use only. RESUME Influenza is mainly caused by a viral infection in the upper respiratory tract (nasal cavity, throat and bronchi) and only a few influenza are caused by a viral infection in the upper respiratory tract. lung. In general, the infection lasts about a week. The main clinical signs are: sudden high fever, muscle pain, headache, restlessness, dry cough, sore throat and rhinitis.
In infants, the elderly, or people susceptible to cancer, diabetes, cardiovascular and pulmonary diseases, the vast majority of patients do not need treatment. self-healing in 1-2 weeks. Infections can lead to many serious complications, such as pneumonia and even death. Influenza viruses are mainly influenza A and influenza B; They exist for influenza A subtypes: H3N2, H1N1, H5N1, and H7N9.
Respiratory syncytial virus (RSV) is one of the most important causes of Tract infection (including bronchiolitis and pneumonia) in babies less than 1-year-old. The initial symptoms of RSV are similar to mild cold symptoms, such as a runny nose, cough, fever, etc., even shortness of breath. Severe lower respiratory disease can occur at any age, especially in the elderly or with cardiovascular, lung, and lung diseases. immune system diseases. RSV mainly invades the human body through the respiratory tract.
When contaminated hands or objects come in direct contact with the eye or nasal mucosa, it is more likely to become infected. The 2019 novel coronavirus, now known as SARS-CoV-2 (previously known as 2019-nCoV), is a new β-type coronavirus, which is a single-stranded RNA virus that can cause human respiratory infections. Its genetic characteristics are significantly different from the coronavirus associated with severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS).
The site of SARS-CoV-2 is the lower respiratory tract, which has a higher incidence in the elderly. The incubation period of the infection is variable. Common symptoms after SARS-CoV-2 infection includes respiratory symptoms, fever, cough, lack of
breathing and shortness of breath.
In more severe cases, the infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. The WHO has named the disease caused by SARS-CoV-2 as coronavirus disease 2019 (abbreviated “COVID-19”). SARS-CoV-2 is highly contagious and is transmitted mainly through contact, droplets or airways. Beginning
The test kits used latex immunochromatography technology. Influenza A / B: on nitrocellulose membrane, McAb2 against influenza A virus and McAb 2 against influenza B were coated on the detection line (T2) and (T1) respectively, goat anti-mouse IgG was coated at the position of the quality control line (C), and the mouse Influenza A / B virus monoclonal antibody 1 labelled with red latex microspheres is fixed on the latex bonding pad.